Transcription of PRODUCT MONOGRAPH - Sanofi
{{id}} {{{paragraph}}}
PLAVIX PRODUCT MONOGRAPH Page 1 of 55 PRODUCT MONOGRAPH PrPLAVIX Clopidogrel Tablets, Manufacturer s Standard 75 and 300 mg Clopidogrel, as clopidogrel bisulfate Platelet Aggregation Inhibitor Sanofi -aventis Canada Inc. 2905 Place Louis-R. Renaud Laval (Qu bec) H7V 0A3 Date of Revision: March 9, 2018 Submission Control No: 211788 s-a Version dated March 9, 2018 PLAVIX PRODUCT MONOGRAPH Page 2 of 55 Table of Contents PART I: HEALTH PROFESSIONAL information .. 3 SUMMARY PRODUCT information .. 3 INDICATIONS AND CLINICAL USE .. 3 CONTRAINDICATIONS .. 4 WARNINGS AND PRECAUTIONS .. 4 ADVERSE REACTIONS .. 7 DRUG INTERACTIONS .. 16 DOSAGE AND ADMINISTRATION .. 21 OVERDOSAGE .. 21 ACTION AND CLINICAL PHARMACOLOGY.
PLAVIX Product Monograph Page 2 of 55 . Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ..... 3
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
APO-PANTOPRAZOLE TABLETS NAME OF THE, PRODUCT INFORMATION, Pantoprazole, Salpraz, Pantoprazole sodium sesquihydrate, Product, API Product List, Medicine Regulations 1984 that reference the manufacturer’s original, Information, Public assessment report, MAXIMUM ALLOWABLE, INFINITI CYP2C19 Assay, Sunset over the Pacific, UESTION OF THE, Sunset over the Pacific UESTION OF THE WEEK 2